Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP-01.1 influenza A vaccine challenge study in healthy adults
2013-004612-22Phase 2Completed
- Sponsor
- Immune Targeting Systems
- Start
- Dec 2013
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing Vaccine FP-01.1 with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Dec 2013; status: completed.
02
Drugs
FP-01.1
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2013-004612-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004612-22.